Miyoshi, A., Kameda, H., Nagai, S., Nakamura, A., Miya, A., Takase, T., . . . Miyoshi, H. (2020). Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis. J Diabetes Investig.
Citação norma ChicagoMiyoshi, Arina, Hiraku Kameda, So Nagai, Akinobu Nakamura, Aika Miya, Takahiro Takase, Tatsuya Atsumi, and Hideaki Miyoshi. "Beneficial Effects of Switching to Denosumab From Bisphosphonates or Selective Estrogen Receptor Modulators in Postmenopausal Women With Type 2 Diabetes and Osteopenia/osteoporosis." J Diabetes Investig 2020.
MLA CitationMiyoshi, Arina, et al. "Beneficial Effects of Switching to Denosumab From Bisphosphonates or Selective Estrogen Receptor Modulators in Postmenopausal Women With Type 2 Diabetes and Osteopenia/osteoporosis." J Diabetes Investig 2020.